Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: Increased concentration of CD33 antigen predicts poor outcome—A report from the childrens cancer study group-Reference-Cited by-同舟云学术

Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: Increased concentration of CD33 antigen predicts poor outcome—A report from the childrens cancer study group

Published:1992 Issue:3 Volume:20 Page:192-200
ISSN:0098-1532
Container-title:Medical and Pediatric Oncology
language:en
Short-container-title:Med. Pediatr. Oncol.

Author:

Dinndorf Patricia A.,Buckley Jonathan D.,Nesbit Mark E.,Lampkin Beatrice C.,Piomelli Sergio,Feig Stephen A.,Kersey John H.,Hammond G. Denman,Bernstein Irwin D.

Publisher

Wiley

Subject

Cancer Research,Oncology,Pediatrics, Perinatology, and Child Health

Reference25 articles.

1. Expression of normal myeloid-associated antigens by acute leukemia cells

2. : Joint report of the Myeloid Section of the Second International Workshop on Human Leucocyte Differentiation Agents. In , , (eds): “Leucocyte Typing II” Vol 3. Berlin: Springer-Verlag, 1986, p. 1.

3. Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies

4. Surface marker analysis of acute myeloblastic leukemia: identification of differentiation-associated phenotypes

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies;Acta Haematologica;2023-09-06

2. CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin;Cancers;2021-06-28

3. References;Flow Cytometry of Hematological Malignancies;2021-04-06

4. Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment;International Journal of Molecular Sciences;2020-08-06

5. Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group;Clinical Cancer Research;2015-12-07